Reduced ATR or Chk1 expression leads to chromosome instability and chemosensitization of mismatch repair-deficient colorectal cancer cells.
about
Trial Watch: Targeting ATM-CHK2 and ATR-CHK1 pathways for anticancer therapyCheckpoint signaling, base excision repair, and PARP promote survival of colon cancer cells treated with 5-fluorodeoxyuridine but not 5-fluorouracil.Distinct gene expression signatures in lynch syndrome and familial colorectal cancer type x.Poly(ADP-Ribose) polymerase inhibition synergizes with 5-fluorodeoxyuridine but not 5-fluorouracil in ovarian cancer cells.Analysis of mutations that dissociate G(2) and essential S phase functions of human ataxia telangiectasia-mutated and Rad3-related (ATR) protein kinase.Identification of DNA repair pathways that affect the survival of ovarian cancer cells treated with a poly(ADP-ribose) polymerase inhibitor in a novel drug combination.Glucose deprivation is associated with Chk1 degradation through the ubiquitin-proteasome pathway and effective checkpoint response to replication blocksCdc6 contributes to cisplatin-resistance by activation of ATR-Chk1 pathway in bladder cancer cells.Selective tumor killing based on specific DNA-damage response deficiencies.DNA Damage Response-Independent Role for MDC1 in Maintaining Genomic StabilityProspects for the Use of ATR Inhibitors to Treat Cancer.P38MAPK is a major determinant of the balance between apoptosis and autophagy triggered by 5-fluorouracil: implication in resistance.Persimmon leaf extract inhibits the ATM activity during DNA damage response induced by Doxorubicin in A549 lung adenocarcinoma cells.Zbtb1 Safeguards Genome Integrity and Prevents p53-Mediated Apoptosis in Proliferating Lymphoid Progenitors
P2860
Q26745686-A59B4E8E-8BFA-47EC-AB47-1B6E9325076CQ34110442-255523DB-54AD-4B36-95F0-5FF90C55B40BQ34950524-8CC50879-A818-466D-92FF-7385B966A1ABQ35112912-AB82F60D-3C4A-4DEC-B454-1FA965972A38Q35423647-F7C07B4C-CFDF-4B23-96B3-3859880ED8B0Q36294441-F9BFA086-578A-4F88-A04A-B985F1F3955FQ37188498-0DB1126C-B22B-4C92-BFA3-0DC66316E396Q37457876-3E2BA7C8-F2D8-4F3C-833B-A19DECABE871Q37976982-D6EB8FA9-8938-4D1B-931C-C1D5841D2C9DQ38716604-24A785D7-80D5-4598-91EA-7DA2465D3188Q38974279-F2B8DA0A-C50F-4B80-9F7D-615E1ECBDEC3Q39490275-0F648930-AF79-4798-BA1A-D9A6DCD575C2Q39554874-F6618F19-2664-490F-854F-D863965E7267Q42147670-CFBCCF73-EFD9-4075-95DF-B183A8D296B7
P2860
Reduced ATR or Chk1 expression leads to chromosome instability and chemosensitization of mismatch repair-deficient colorectal cancer cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Reduced ATR or Chk1 expression ...... cient colorectal cancer cells.
@en
Reduced ATR or Chk1 expression ...... cient colorectal cancer cells.
@nl
type
label
Reduced ATR or Chk1 expression ...... cient colorectal cancer cells.
@en
Reduced ATR or Chk1 expression ...... cient colorectal cancer cells.
@nl
prefLabel
Reduced ATR or Chk1 expression ...... cient colorectal cancer cells.
@en
Reduced ATR or Chk1 expression ...... cient colorectal cancer cells.
@nl
P2093
P2860
P356
P1476
Reduced ATR or Chk1 expression ...... cient colorectal cancer cells.
@en
P2093
Barbara K Goodman
Melanie J Jardim
Qinhong Wang
Ryohei Furumai
Timothy Wakeman
Xiao-Fan Wang
P2860
P304
P356
10.1091/MBC.E09-04-0303
P577
2009-07-01T00:00:00Z